Pharma channel feed

Re­gen­eron’s $500M fund spot­lights cor­po­rate ven­ture’s in­flu­en­tial role in biotech

Last year
Financing
Startups

Mar­ket­ing pay­ments to can­cer doc­tors lead to more pre­scrip­tions but not bet­ter out­comes, NBER pa­per finds

Last year
Marketing

Car­di­nal Health los­es Op­tum­Rx con­tract to McKesson

Last year

Pfiz­er to shut­ter re­search op­er­a­tions at Col­orado site ac­quired in Ar­ray deal

Last year
People

Take­da wins la­bel ex­pan­sion for sub­cu­ta­neous En­tyvio, cre­at­ing 'flex­i­bil­i­ty' for Crohn's pa­tients

Last year
FDA+

CSL Vi­for pro­pos­es a mar­ket­ing cam­paign to set­tle Eu­ro­pean Com­mis­sion in­ves­ti­ga­tion

Last year
Marketing

Sen­a­tors want to know more on why No­vo is dis­con­tin­u­ing its in­sulin Lev­emir

Last year

Califf talks bol­ster­ing do­mes­tic drug man­u­fac­tur­ing, for­eign in­spec­tions at House hear­ing

Last year
FDA+

Roche's Genen­tech touts la­bel ex­pan­sion for block­buster lung can­cer drug Ale­cen­sa

Last year

Con­sumer trust in physi­cians and phar­ma is up, but low­er for em­ploy­ers and biotech

Last year
Marketing

Sanofi re­struc­tures US com­mer­cial vac­cines sales force

Last year
Marketing

Lu­mi­cell nabs FDA ap­proval for drug-de­vice breast can­cer de­tec­tion sys­tem

Last year
FDA+
Diagnostics

GSK un­veils long-term Shin­grix da­ta as shin­gles com­pe­ti­tion heats up

Last year
R&D

Lil­ly, in­sulin users end $13.5M set­tle­ment plan fol­low­ing fed­er­al judge's de­ci­sion

Last year
Law

A ma­jor­i­ty of phar­ma and biotech com­pa­nies pro­hib­it Chat­G­PT use, sur­vey finds

Last year
AI

Ab­b­Vie inks deal for Med­in­cell's long-act­ing in­jectable plat­form worth up to $1.9B

Last year
Deals

Re­gen­eron and Genen­tech bat­tle for oph­thal­mol­o­gists’ affin­i­ty in Eylea HD, Vabysmo matchup

Last year
Marketing

FDA hits Nat­co with warn­ing let­ter over In­dia fa­cil­i­ty, sus­pends prod­uct ship­ments to US

Last year
FDA+

San­doz's Hu­mi­ra biosim­i­lar nabs sig­nif­i­cant mar­ket share thanks to CVS part­ner­ship

Last year

J&J’s mul­ti­ple myelo­ma ther­a­pies dri­ve on­col­o­gy busi­ness de­spite slow Carvyk­ti sales

Last year

Charles Riv­er promis­es $500M for ini­tia­tive to de­vel­op al­ter­na­tive test­ing meth­ods and re­duce use of an­i­mals

Last year

How drug­mak­ers are han­dling new pres­sure to re­cy­cle plas­tic in­jec­tion pens as mil­lions of new pa­tients be­gin us­ing GLP-1s

Last year
Marketing

Mar­ket­ingRx roundup: Vi­a­tris taps for­mer Mod­er­na ex­ec for com­mer­cial chief; Mer­ck de­buts PAH ef­fort

Last year
Marketing

Cor­rec­tion: Boehringer In­gel­heim touts 10-year plan as it eyes over­tak­ing Bay­er as Ger­many’s largest phar­ma

Last year
First page Previous page 60616263646566 Next page Last page
A service from the Financial Times